SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Baron R 1989 Molecular mechanisms of bone resorption by the osteoclast. Anat Rec 224: 317324.
  • 2
    Suda T, Takahashi N, Martin TJ 1992 Modulation of osteoclast differentiation. Endocr Rev 13: 6680.
  • 3
    Roodman GD 1996 Advances in bone biology: the osteoclast. Endcr Rev 17: 308332.
  • 4
    Burger EH, Van der Meer JW, van de Gevel JS, Gribnau JC, Thesingh GW, van Furth R 1982 In vitro formation of osteoclasts from long-term cultures of bone marrow mononuclear phagocytes. J Exp Med 156: 16041614.
  • 5
    Ibbotson KJ, Roodman GD, McManus LM, Mundy GR 1984 Identification and characterization of osteoclast-like cells and their progenitors in culture of feline marrow mononuclear cells. J Cell Biol 99: 471480.
  • 6
    Kurihara N, Suda T, Miura Y, Nakauchi H, Kodama H, Hiura K, Hakeda Y, Kumegawa M 1989 Generation of osteoclasts from isolated hematopoietic progenitor cells. Blood 74: 12951302.
  • 7
    Helfrich MH, Nesbitt SA, Dorey EL, Horton MA 1992 Rat osteoclasts adhere to wide range of RGD (Arg-Gly-Asp) peptide-containing proteins, including the bone sialoproteins and fibronectin, via a β3 integrin. J Bone Miner Res 7: 335343.
  • 8
    Horton MA, Dorey EL, Nesbitt SA, Samanen J, Ali FE, Stader JM, Nichol A, Greg R, Helfrich MH 1993 Modulation of vitronectin receptor-mediated osteoclast adhesion by Arg-Gly-Asp peptide analogs: A structure-function analysis. J Bone Miner Res 8: 239247.
  • 9
    Teti A, Marchisio PC, Zambonin-Zallone A 1991 Clear zone in osteoclast function: Role of podosomes in regulation of bone-resorbing activity. Am J Physiol 261: C1C7.
  • 10
    Aubin JE 1992 Osteoclast adhesion and resorption: the role of podosomes. J Bone Miner Res 7: 365368.
  • 11
    Suda T, Nakamura I, Jimi E, Takahashi N 1997 Regulation of osteoclast function. J Bone Miner Res 12: 869879.
  • 12
    Sugawara K, Hamada M, Hosoi S, Tamaoki T 1998 A useful method to evaluate bone resorption inhibitors, using osteoclast-like multinucleated cells. Anal Biochem 255: 204210.
  • 13
    Blair HC, Jordan SE, Peterson TG, Barnes S 1996 Variable effects of tyrosine kinase inhibitors on avian osteoclastic activity and reduction of bone loss in ovariectomized rats. J Cell Biochem 61: 629637.
  • 14
    Feuerbach D, Waelchli R, Fehr T, Feyen JH 1995 Mycotrienins. A new class of potent inhibitors of osteoclastic bone resorption. J Biol Chem 270: 2594925955.
  • 15
    Tanaka S, Takahashi N, Udagawa N, Murakami H, Nakamura I, Kurokawa T, Suda T 1995 Possible involvement of focal adhesion kinase, p125FAK, in osteoclastic bone resorption. J Cell Biochem 58: 424435.
  • 16
    Hall TJ, Schaeublin M, Missbach M 1994 Evidence that c-src is involved in the process of osteoclastic bone resorption. Biochem Biophys Res Commun 199: 12371244.
  • 17
    Nakamura I, Jimi E, Duong LT, Sasaki T, Takahashi N, Rodan GA, Suda T 1998 Tyrosine phospharylation of p130cas is involved in actin organization in osteoclasts. J Biol Chem 273: 1114411149.
  • 18
    Hall TJ, Jeker H, Schaueblin M 1995 Wortmannin, a potent inhibitor of phosphatidylinositol 3-kinase, inhibits osteoclastic bone resorption in vitro. Calcif Tissue Int 56: 336338.
  • 19
    Nakamura I, Takahashi N, Sasaki T, Tanaka S, Udagawa N, Murakami H, Kimura K, Kabuyama Y, Kurokawa T, Suda T 1995 Wortmannin, a specific inhibitor of phosphatidylinositol-3 kinase, blocks osteoclastic bone resorption. FEBS Lett 361: 7984.
  • 20
    Orcel P, Denne MA, de Vernejoul MC 1991 Cyclosporin-A in vitro decreases bone resorption, osteoclast formation, and the fusion of cells of the monocyte-macrophage lineage. Endocrinology 128: 16381646.
  • 21
    Movsowitz C, Epstein S, Ismail F, Fallon M, Thomas S 1989 Cyclosporin A in the ovariectomized rat: unexpected severe bone resorption. J Bone Miner Res 4: 393398.
  • 22
    Kameda T, Miyazawa K, Mori Y, Yuasa T, Shiokawa M, Nakamaru Y, Mano H, Hakeda Y, Kameda A, Kumegawa M 1996 Vitamin K2 inhibits osteoclastic bone resorption by inducing osteoclast apoptosis. Biochem Biophys Res Commun 220: 515519.
  • 23
    Hara K, Akiyama Y, Nakamura T, Murota S, Morita I 1995 The inhibitory effect of vitamin K2 (menatetrenone) on bone resorption may be related to its side chain. Bone 16: 179184.
  • 24
    Notoya K, Yoshida K, Shirakawa Y, Taketomi S, Tsuda M 1995 Similarities and differences between the effects of ipriflavone and vitamin K on bone resorption and formation in vitro. Bone 16: 349S353S.
  • 25
    Akiyama Y, Hara K, Tajima T, Murota S, Morita I 1994 Effect of vitamin K2 (menatetrenone) on osteoclast-like cell formation in mouse bone marrow cultures. Eur J Pharmacol 263: 181185.
  • 26
    Okahashi N, Nakamura I, Jimi E, Koide M, Suda T, Nishihara T 1997 Specific inhibitors of vacuolar H(+)-ATPase trigger apoptotic cell death of osteoclasts. J Bone Miner Res 12: 11161123.
  • 27
    Sundquist K, Lakkakorpi P, Wallmark B, Vaananen K 1990 Inhibition of osteoclast proton transport by bafilomycin A1 abolishes bone resorption. Biochem Biophys Res Commun 168: 309313.
  • 28
    Woo JT, Ohba Y, Tagami K, Sumitani K, Kataoka T, Nagai K 1997 Prodigiosin 25-C and metacycloprodigiosin suppress the bone resorption by osteoclasts. Biosci Biotech Biochem 61: 400402.
  • 29
    Everts V, Beertsen W, Schroder R 1988 Effects of the protease inhibitors leupeptin and E-64 on osteoclastic bone resorption. Calcif Tissue Int 43: 172178.
  • 30
    Kakegawa H, Nikawa T, Tagami K, Kamioka H, Sumitani K, Kawata T, Drobnic-Kosorok M, Lenarcic B, Turk V, Katunuma N 1993 Participation of cathepsin L on bone resorption. FEBS Lett 321: 247250.
  • 31
    Notoya K, Yoshida K, Taketomi S, Yamazaki I, Kumegawa M 1993 Inhibitory effect of ipriflavone on osteoclast-mediated bone resorption and new osteoclast formation in long-term cultures of mouse unfractionated bone cells. Calcif Tissue Int 53: 206209.
  • 32
    Bonucci E, Ballanti P, Martelli A, Mereto E, Brambilla G, Bianco P, Bufalino L 1992 Ipriflavone inhibits osteoclast differentiation in parathyroid transplanted parietal bone of rats. Calcif Tissue Int 50: 314319.
  • 33
    Morita I, Sakaguchi K, Kurachi T, Murota S 1992 Ipriflavone inhibits murine osteoclast formation in vitro. Calcif Tissue Int 51: S710.
  • 34
    Notoya K, Yoshida K, Taketomi S, Yamazaki I, Kumegawa M 1992 Inhibitory effect of ipriflavone on pit formation in mouse unfractionated bone cells. Calcif Tissue Int 51: S3S6.
  • 35
    Kameda T, Mano H, Yuasa T, Mori Y, Miyazawa K, Shiokawa M, Nakamaru Y, Hiroi E, Hiura K, Kameda A, Yang NN, Hakeda Y, Kumegawa M 1997 Estrogen inhibits bone resorption by directly inducing apoptosis of the bone-resorbing osteoclasts. J Exp Med 186: 489495.
  • 36
    Turner RT, Wakley GK, Hannon KS, Bell NH 1988 Tamoxifen inhibits osteoclast-mediated resorption of trabecular bone in ovarian hormone-deficient rats. Endcrinol 122: 11461150.
  • 37
    Endo A, Kuroda M, Tsujita Y 1976 ML-236A, ML236-B, and ML-236C, new inhibitors of cholesterogenesis produced by Penicillium citrinium. J Antibiot (Tokyo) 29: 13461348.
  • 38
    Alberts AW 1988 Discovery, biochemistry and biology of lovastatin. Am J Cardiol 62: 10J15J.
  • 39
    Prendergast GC, Davide JP, DeSolms SJ, Giuliani EA, Graham SL, Gibbs JB, Oliff A, Kohl NE 1994 Farnesyltrasferase inhibition causes morphological reversion of Ras-transformed cells by a complex mechanism that involves regulation of the actin cytoskeleton. Mol Cell Biol 14: 41934202.
  • 40
    Lerner EC, Qian Y, Blaskovich MA, Fossum RD, Vogt A, Sun J, Cox AD, Der CJ, Hamiltone AD, Sebti SM 1995 Ras CAAX peptidomimetic FTI-277 selectively blocks oncogenic Ras signaling by inducing cytoplasmic accumulation of inactive Ras-Raf complexes. J Biol Chem 270: 2680226806.
  • 41
    Perez Sala D, Mollinedo F 1994 Inhibition of isoprenoid biosynthesis induces apoptosis in human promyelocytic HL-60 cells. Biochem Biophys Res Commun 199: 12091215.
  • 42
    Stark WW, Blaskovich MA, Johnson BA, Qian Y, Vasudevan A, Pitt B, Hamilton AD, Sebti SM, Davies P 1998 Inhibiting geranylgeranylation blocks growth and promotes apoptosis in pulmonary vascular smooth muscle cells. Am J Physiol 275: L5563.
  • 43
    Luckman SP, Hughes DE, Coxon FP, Russel RGG, Rogers MJ 1998 Nitrogen-containing bisphosphonates inhibit the mevalonate pathway and prevent post-translational prenylation of GTP-binding proteins, including Ras. J Bone Miner Res 13: 581589.
  • 44
    Takahashi N, Yamana H, Yoshiki S, Roodman GD, Mundy GR, Jones SJ, Boyde A, Suda T 1988 Osteoclast-like cell formation and its regulation by osteotropic hormone in mouse bone marrow cultures. Endocrinology 122: 13731382.
  • 45
    Takami M, Woo JT, Nagai K 1998 Requirement of osteoblastic cells for the fusion of preosteoclasts. J Bone Miner Metab 16: 151157.
  • 46
    Raisz LG 1965 Bone resorption in tissue culture: Factors in fluencing the response to parathyroid hormone. J Clin Invest 44: 103116.
  • 47
    Jimi E, Nakamura I, Duong LT, Ikebe T, Takahashi N, Rodan GA and Suda T 1999 Interleukin 1 induces multinucleation and bone-resorbing activity of osteoclasts in the absence of osteoblasts/stromal cells. Exp Cell Res 247: 8493.
  • 48
    Jimi E, Akiyama S, Tsurukai T, Okahashi N, Kobayashi K, Udagawa N, Nishihara T, Takahashi N, Suda T 1999 Osteoclast differentiation factor acts as a multifunctional regulator in murine osteoclast differentiation and function. J Immunol 163: 434442.
  • 49
    Coxon FP, Benford HL, Russell RGG, Rogers MJ 1998 Protein synthesis is required for caspase activation and induction of apoptosis by bisphosphonate drugs. Mol Pharmacol 54: 631638.
  • 50
    Amin D, Cornell SA, Gustafson SK, Needle SJ, Ullrich JW, Bilder GE, Perrone MH 1992 Bisphosphonates used for the treatment of bone disorders inhibit squalene synthase and cholesterol biosynthesis. J Lipid Res 33: 16571663.
  • 51
    Amin D, Cornell SA, Perrone MH, Bilder GE 1996 1-hydroxy-3-(metylpentylamino)-propylidene-1,1-bisphosphanic acid as a potent inhibitor of squalene synthase. Arzneimittelforschung 46: 759762.
  • 52
    Rogers MJ, Chilton KM, Coxon F, Lawry J, Smith MO, Suri S, Russell RGG 1996 Bisphosphonates induce apoptosis in mouse macrophage-like cells by a nitric-oxide-independent mechanism. J Bone Miner Res 11: 14821491.
  • 53
    Suda T, Udagawa N, Takahashi N 1996 Cells of bone: Osteoclast generation. In: BilezikianJP, RaiseLG, RodanGA (eds.) Priciples of Bone Biology. Academic Press, San Diego, CA, U.S.A., pp. 87102.
  • 54
    Fisher JE, Rogers MJ, Halasy JM, Luckman SP, Hughes DE, Masarachia PJ, Wesolowski G, Russel RGG, Rodan GA, Reszka AA 1999 Alendronate mechanism of action: Geranylgeraniol reverses inhibition of osteoclast formation, bone resorption and kinase activation in vitro. Proc Natl Acad Sci U S A 96: 133138.
  • 55
    Fenton RG, Kung HF, Longo DL, Smith MR 1992 Regulation of intracellular actin polymerization by prenylated cellular proteins. J Cell Biol 117: 347356.
  • 56
    Koch G, Benz C, Scmidt G, Olenik C, Aktories K 1997 Role of Rho protein in lovastatin-induced breakdown of actin cytoskeleton. J Phamacol Exp Ther 283: 901909.
  • 57
    Glomset JA, Gelb MH, Farnsworth CC 1992 Geranylgeranylated proteins. Biochem Soc Trans 20: 479484.
  • 58
    Zhang D, Udagawa N, Nakamura I, Murakami H, Saito S, Yamazaki K, Shibasaki Y, Morii N, Narumiya S, Takahashi N, Suda T 1995 The small GTP binding protein, Rho p21, is involved in bone resorption by regulating cytoskeletal organization in osteoclast. J Cell Sci 108: 22852292.
  • 59
    Palokangas H, Mulari M, Vaananen HK 1997 Endocytotic pathway from the basal plasma membrane to the ruffled border membrane in bone-resorbing osteoclasts. J Cell Sci 110: 17671780.
  • 60
    Halsy JM, Rodan GA, Reszka AA 1998 Relationship of alendronate effects to osteoclast apoptosis. J Bone Miner Res 23: S552.
  • 61
    Koshihara Y, Kodama S, Ishibashi H, Azuma Y, Ohta T, Karube S 1999 Reversibility of alendronate-induced contraction in human osteoclast-like cells formed from bone marrow cells in culture. J Bone Miner Metab 17: 98107.